Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Jan;69(1):13-14.
doi: 10.1161/HYPERTENSIONAHA.116.08222. Epub 2016 Oct 31.

Acid Test for Nitrite Pharmacology

Affiliations
Editorial

Acid Test for Nitrite Pharmacology

Barbora Piknova et al. Hypertension. 2017 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

ANS is a co-inventor on a patent to the NIH for therapeutic uses of nitrite ions. BP has no conflict of interest to declare.

Figures

Figure
Figure. Overview of Nitric Oxide (NO) Metabolism in Humans
This schematic diagram illustrates current understanding of major pathways of NO formation and consumption in mammals, including human beings. In the last decade pathways for reduction of nitrate to nitrite and nitrite to form NO have been extensively studied, in addition to the more classical NO formation from arginine by the three groups of nitric oxide synthase (NOS I, II, and III) enzymes. Some of the major mechanisms of these reductive pathways, as well as the oxidative pathways, are shown. Nitrate reductase enzymes in salivary and possibly gut bacteria can reduce oral nitrate (both from immediate ingestion and that secreted into the mouth from blood by the salivary glands) to nitrite and stomach acid reduces some of this to NO, which is absorbed into the bloodstream along with the remaining nitrite and nitrate. The current paper reports that gastric acidification is important for the therapeutic goal of lowering systolic blood pressure with oral nitrite but that this ion has no affect on blood pressure if given intravenously, although the mechanism for this difference is not clear. XOR: xanthine oxidoreductase enzyme; oxyHb: oxyhemoglobin; oxyMb: oxymyoglobin.

Comment on

References

    1. Weitzberg E, Lundberg JO. Novel aspects of dietary nitrate and human health. Annu Rev Nutr. 2013;33:129–159. - PubMed
    1. Pinheiro LC, Montenegro MF, Amaral JH, Ferreira GC, Oliveira AM, Tanus-Santos JE. Increase in gastric pH reduces hypotensive effect of oral sodium nitrite in rats Free. Radic Biol Med. 2012;53:701–709. - PubMed
    1. Shah NH, LePendu P, Bauer-Mehren A, Ghebremariam YT, Iyer SV, Marcus J, Nead KT, Cooke JP, Leeper NJ. Proton pump inhibitor usage and the risk of myocardial infarction in the general population. PLoS One. 2015;10:e0124653. - PMC - PubMed
    1. Hunault CC, van Velzen AG, Sips AJ, Schothorst RC, Meulenbelt J. Bioavailability of sodium nitrite from an aqueous solution in healthy adults. Toxicol Lett. 2009;190:48–53. - PubMed
    1. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, Cannon RO, 3rd, Gladwin MT. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med. 2003;12:1498–1505. - PubMed